Structure‐based design of inhibitors of protein–protein interactions: mimicking peptide binding epitopes

M Pelay‐Gimeno, A Glas, O Koch… - Angewandte Chemie …, 2015 - Wiley Online Library
Protein–protein interactions (PPIs) are involved at all levels of cellular organization, thus
making the development of PPI inhibitors extremely valuable. The identification of selective …

Comprehensive review in current developments of imidazole‐based medicinal chemistry

L Zhang, XM Peng, GLV Damu… - Medicinal research …, 2014 - Wiley Online Library
Imidazole ring is an important five‐membered aromatic heterocycle widely present in natural
products and synthetic molecules. The unique structural feature of imidazole ring with …

Inhibition of α-helix-mediated protein–protein interactions using designed molecules

V Azzarito, K Long, NS Murphy, AJ Wilson - Nature chemistry, 2013 - nature.com
Inhibition of protein–protein interactions (PPIs) represents a significant challenge because it
is unclear how they can be effectively and selectively targeted using small molecules …

Targeting rac and Cdc42 GTPases in cancer

MM Maldonado, S Dharmawardhane - Cancer research, 2018 - AACR
Rac and Cdc42 are small GTPases that have been linked to multiple human cancers and
are implicated in epithelial to mesenchymal transition, cell-cycle progression …

Modulating reactivity and diverting selectivity in palladium-catalyzed heteroaromatic direct arylation through the use of a chloride activating/blocking group

B Liégault, I Petrov, SI Gorelsky… - The Journal of Organic …, 2010 - ACS Publications
Through the introduction of an aryl chloride substituent, the selectivity of palladium-catalyzed
direct arylation may be diverted to provide alternative regioisomeric products in high yields …

Tackling undruggable targets with designer peptidomimetics and synthetic biologics

CS Swenson, G Mandava, DM Thomas… - Chemical …, 2024 - ACS Publications
The development of potent, specific, and pharmacologically viable chemical probes and
therapeutics is a central focus of chemical biology and therapeutic development. However, a …

State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors

C Sheng, G Dong, Z Miao, W Zhang… - Chemical Society …, 2015 - pubs.rsc.org
Targeting protein–protein interactions (PPIs) has emerged as a viable approach in modern
drug discovery. However, the identification of small molecules enabling us to effectively …

Targeting Rac and Cdc42 GEFs in metastatic cancer

MDM Maldonado, JI Medina, L Velazquez… - Frontiers in cell and …, 2020 - frontiersin.org
The Rho family GTPases Rho, Rac, and Cdc42 have emerged as key players in cancer
metastasis, due to their essential roles in regulating cell division and actin cytoskeletal …

Disrupting protein–protein interactions with non-peptidic, small molecule α-helix mimetics

CG Cummings, AD Hamilton - Current opinion in chemical biology, 2010 - Elsevier
Many biological processes are regulated by protein–protein interactions (PPIs) and as such
their misregulation can cause a multitude of diseases. Often the interactions between large …

Peptidomimetics: a synthetic tool for inhibiting protein–protein interactions in cancer

L Mabonga, AP Kappo - International Journal of Peptide Research and …, 2020 - Springer
Protein–protein interactions (PPI) are vital in modulating biochemical pathways in many
biological processes. Inhibiting PPI is a tremendously important diagnostic and therapeutic …